Cancer · May 13, 2026
China Approves Clinical Trials for Dual-Action Cancer Drug SKB118
Kelun-Biotech's innovative PD-1 x VEGF bispecific antibody receives investigational approval for cancer treatment....
Technology · May 11, 2026
AI Tool Shows Promise for Predicting Immune Responses in Cancer Care
AI technology is being evaluated for real-world drug discovery applications, promising faster development of new medicines....